Benzinga's Top Upgrades
October 23, 2014 at 08:45 AM EDT
Goldman Sachs upgraded Boston Scientific (NYSE: BSX) from Sell to Neutral. The price target for Boston Scientific has been raised from ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|